Important Disclosure from Rathbones Group Plc on Assura Plc

Crucial Insights on Rathbones Group Plc's Position in Assura Plc
In the dynamic world of finance, transparent disclosures are pivotal for investors and stakeholders alike. The latest statement from Rathbones Group Plc regarding their interest in Assura Plc serves as an essential reference for market participants, revealing key ownership details and dealings. Following the requirements under the regulatory framework, this disclosure shows Rathbones Group Plc's level of engagement with Assura Plc, a notable player in the healthcare real estate market.
Key Information Shared by Rathbones Group Plc
The primary disclosure highlights vital information that investors must scrutinize. The full name of the discloser—Rathbones Group Plc—indicates their significant position in Assura Plc, whose relevant securities are classified within the health sector. Investors should note that this is a position comprising 1% or more of the securities, which emphasizes the importance of this record.
Interests and Short Positions Detailed
This disclosure outlines specific interests held by Rathbones Group Plc in Assura Plc. They hold a substantial position of 153,293,362 shares, amounting to approximately 4.71% of the total relevant securities. Notably, this figure is significant as it highlights not only the control exerted over a considerable shareholding but also establishes Rathbones Group's influential status in Assura Plc's operations.
Recent Transactions Highlighted
Recent dealings by Rathbones Group Plc included various sales and purchases of Assura’s ordinary shares. For example, notable sales comprised transactions where the share prices fluctuated between 42.254p and 42.6992p for listed shares. These actions reflect active portfolio management strategies geared towards optimizing returns while maintaining compliance with regulatory standards.
Detailed Nature of Dealings
Rathbones has disclosed their engagements in buying and selling activities concerning Assura Plc’s 10p ordinary shares. Highlighted transactions included sales of 4,829 shares at prices reaching 42.6596p, alongside the purchase of 83,190 shares at 42.254p. These transactions are indicative of strategic shifts in Rathbones’ investment strategy, responding to market volatility and potential growth opportunities associated with Assura Plc. Investors must track these changes closely as they can indicate broader market sentiments.
Stock-Settled Derivative Transactions
The firm also commented on cash-settled and stock-settled derivative transactions, including the nature of these dealings. As no significant cash-settled derivatives were reported, a keen focus remains on future dealings related to stock settlements. This lack of current activity does not imply their absence in future strategies, and monitoring these financial instruments is crucial for stakeholders.
Other Arrangements and Understandings
Rathbones Group has publicly stated in their disclosure that there are no indemnity or dealing arrangements currently in play. This transparency showcases their compliance with regulatory standards, thus maintaining a loyal investor base that highly values integrity and clarity. All dealings are recorded formally to ensure that stakeholders receive updates about any agreements that may influence transaction patterns concerning Assura Plc.
Contact Information for Further Inquiries
For those looking for further details about this disclosure or have administrative queries, Rathbones Group Plc has provided the contact information of Chinwe Enyi from the Compliance Department. Interested parties may reach out at the given contact number, enhancing communication lines and ensuring that stakeholders can easily seek clarity on matters discussed. The telephone number for inquiries is 0151 243 7053.
Frequently Asked Questions
What is the significance of Rathbones Group’s disclosure?
This disclosure highlights Rathbones Group Plc's substantial interest in Assura Plc, which is significant for investors tracking market movements and the company's financial health.
How many shares does Rathbones Group own in Assura Plc?
Rathbones Group holds 153,293,362 shares in Assura Plc, making up approximately 4.71% of the company's total securities.
Are there any recent transactions conducted by Rathbones related to Assura?
Yes, recent transactions included several sales and purchases of Assura’s ordinary shares, with recorded sales at varying prices reflecting strategic portfolio management.
Who can I contact for more details about these disclosures?
For inquiries, you can contact Chinwe Enyi from the Compliance Department at Rathbones Group Plc by dialing 0151 243 7053.
Are there any arrangements or understandings regarding securities?
Currently, there are no indemnity or dealing arrangements entered into by Rathbones Group relating to Assura Plc.
About The Author
Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.